speaker

Pav Rishiraj

MS

Medicine

Clinical Pharmacology

Pav Rishiraj is a Director, Head of Pharmacovigilance at Ipsen. A senior Pharmacovigilance (PV)/ Patient Safety leader and expert with extensive detailed experience spanning 21 years across multiple functions including global/local positions, Pav Rishiraj has held previous senior management/leadership positions, primarily alongside QPPVs/VP of PV to ensure strict compliance to UK, European and global regulatory obligations through robust implementation and oversights of the regional/local PV system.

His experience locally and regionally has enabled the facilitation of strong cross-functional collaboration and transformational change across all the organizations he has served. A proactive leader and energizer, through inclusive, empowering leadership, Pav Rishiraj ‘s passionate advocacy and empowering approach to patient safety is apparent in full abundance when he was recognized and installed as the UK Chair of the ABPI Pharmacovigilance Expert Network (PEN). He remains ever committed to ensuring and propelling forward innovative approaches to patient safety and is currently a member of the International Society of Pharmacovigilance (ISoP).

Pav has both strategic and working experience in influencing, shaping, and advocating the PV landscape from an industry perspective- recent highlights include pre/post BREXIT discussions with the MHRA, ABPI PV expert guidance in addition to industry lead wider impact groups. Internally, he has led many teams to audit and inspection successes. Notably, one of his career highlights was his strategic contribution to an overall company-wide R&D strategy.

Pav was recently appointed (May 2022) as a member of the Board Steering Group (BSG) at the ABPI by his peers and colleagues to represent UK PV and drive forward Regulatory Science objectives largely to evolve a robust and respected regulatory framework with a clear strategy for collaboration within the UK and internationally.